Demography | [n (%)] |
---|---|
Children | 151 |
Female | 77 (51.0%) |
Age | |
< 3 years | 39 (25.8%) |
3–5 years | 43 (28.5%) |
6–8 years | 43 (28.5%) |
≥ 9 years | 26 (17.2%) |
Median years [range] | 5.7 [.3–15.4] |
Parent status | [n (%)] |
Two parents alive | 67 (44.4%) |
Only father living | 19 (12.6%) |
Only mother living | 27 (17.9%) |
Neither parent living | 38 (25.1%) |
WHO clinical stage [n (%)] | [n (%)] |
Stage 1 | 26 (17.2%) |
Stage 2 | 19 (12.6%) |
Stage 3 | 72 (47.7%) |
Stage 4 | 34 (22.5%) |
Anthropometry | Median (IQR) |
Weight-for-age Z-score | -1.9 (-3.6 to -0.9) |
Height-for-age Z-score | -2.2 (-3.0 to -1.1) |
CD4 lymphocyte % | [n (%)] |
< 5% | 52 (35.6%) |
5%-9% | 36 (24.7%) |
10%-14% | 28 (19.2%) |
15%-24% | 26 (17.8%) |
> 25% | 4 (2.7%) |
Median CD4% (IQR) | 7.4 (2.1–13.7) |
Laboratory values | Median (IQR) |
Albumin (g/L) | 30.0 (26.0–35.0) |
ALT (IU/L) | 18.0 (14.0–28.3) |
Hemoglobin (g/dl) | 10.1 (8.9–11.0) |
Tuberculosis | [n (%)] |
Present | 50 (33.1%) |
Other opportunistic infections | [n (%)] |
Chronic gastroenteritis | 52 (34.4%) |
Pneumonia | 13 (8.6%) |
Oesophageal candidiasis | 13 (8.6%) |
PCP | 11 (7.3%) |
Cryptococcal meningitis | 1 (0.7%) |
CMV retinitis | 0 |
Toxoplosmosis | 0 |